Recombinant Human VHL protein, Fc Tag (CAT#: PRLP-002)
Please feel free to contact us for a quote and further discussion with our scientists.
Datasheets
| Protein Information |
|---|
| Protein Name |
Recombinant Human VHL protein, Fc Tag |
| Alternative Names |
RCA1; VHL1; pVHL; HRCA1 |
| Gene Name |
VHL |
| Species |
Human |
| Introduction |
Von Hippel-Lindau tumor suppressor (VHL) is the substrate recognition subunit of a CUL2-based E3 ubiquitin ligase complex. It contains an elongin binding domain and a β-domain that recognizes hydroxylated proline residues. |
| Function |
As a pioneer E3 ligase in proximity-induced degradation, VHL (Von Hippel-Lindau) forms the core of the CRL2-VHL complex. It is highly valued for its predictable structural rigidity, low active-site flexibility, and robust expression across most tissue types. VHL allows bifunctional degraders to form highly stable ternary complexes, driving efficient neo-substrate polyubiquitination and proteasomal clearing. |
| Related Disease |
Von Hippel-Lindau disease (retinal hemangiomas, cerebellar/spinal hemangioblastomas, renal cell carcinoma, pheochromocytoma) |
| Gene ID |
7428 |
| UniProt ID |
P40337 |
| Product Specifications |
|---|
| Expression System |
E. coli |
| Expression Length(a.a) |
213 |
| Molecular Weight (kDa) |
28.2 |
| Purity |
0.9 |
| Size |
0.1 mg |
| Physical State |
Aqueous buffer solution |
| Storage |
Stored at -80 °C. Avoid freeze/thaw cycles. |
Our services are For Research Use Only. We do not provide direct services for patients.
